Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Biondvax Pharma ADR (BVXV)
Biondvax Pharma ADR (BVXV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,923
  • Shares Outstanding, K 1,868
  • Annual Sales, $ 0 K
  • Annual Income, $ -12,860 K
  • 60-Month Beta 2.49
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.49
Trade BVXV with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.03 +5.25%
on 03/16/23
2.43 -11.93%
on 03/03/23
-0.21 (-9.13%)
since 02/28/23
3-Month
2.03 +5.25%
on 03/16/23
3.60 -40.56%
on 01/06/23
-0.80 (-27.21%)
since 12/28/22
52-Week
2.03 +5.25%
on 03/16/23
19.65 -89.11%
on 04/05/22
-15.46 (-87.84%)
since 03/28/22

Most Recent Stories

More News
BiondVax Pharmaceuticals’ (NASDAQ: BVXV) NanoAb Holds Potential to Combat COVID-19 Variants

BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune...

BVXV : 2.17 (+3.33%)
BiondVax (NASDAQ: BVXV) Advancing Development of Therapeutic Tech for Multiple Diseases

Leveraging top-tier pharmaceutical industry leadership, extensive drug development expertise, a GMP biologics manufacturing facility, and strategic collaborations with Max Planck Institute for Multidisciplinary...

BVXV : 2.17 (+3.33%)
BiondVax Pharmaceuticals (NASDAQ: BVXV) CEO Featured on ‘Test. Optimize. Scale.’ Podcast Series

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune...

BVXV : 2.17 (+3.33%)
BiondVax (NASDAQ: BVXV) Positioned to Develop NanoAbs for COVID-19 Variants

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products, is working on changing the grim reality caused by the evolution...

BVXV : 2.17 (+3.33%)
BiondVax (NASDAQ: BVXV) Aiming to Capture Market Share for Treatment, Prevention of COVID-19

The Food and Drug Administration (“FDA”) recently withdrew the authorization of AstraZeneca PLC (NASDAQ: AZN) ’s Evusheld, a combination of two monoclonal antibodies (“mAbs”), which was being...

BVXV : 2.17 (+3.33%)
PFE : 40.24 (+0.63%)
AZN : 68.65 (+0.07%)
BiondVax’s (NASDAQ: BVXV) NanoAb May Serve as Therapeutic and Prophylactic

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune...

BVXV : 2.17 (+3.33%)
BiondVax’s (NASDAQ: BVXV) NanoAb Pipeline Targeting Large Underserved Medical Needs

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune...

BVXV : 2.17 (+3.33%)
BiondVax Pharmaceuticals (NASDAQ: BVXV) to Participate in Upcoming Biotech Showcase

BiondVax Pharmaceuticals (NASDAQ: BVXV) CEO Amir Reichman will be presenting at the Biotech Showcase Conference, scheduled for Jan. 9–11, 2023. The conference is being held in San Francisco during the...

JPM : 129.20 (+0.25%)
BVXV : 2.17 (+3.33%)
BiondVax Pharmaceuticals (NASDAQ: BVXV) Releases Business Update

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on the development, manufacturing, and commercialization of innovative immunotherapeutic products used primarily for the treatment...

BVXV : 2.17 (+3.33%)
BiondVax Pharmaceuticals (NASDAQ: BVXV) Releases Letter to Shareholders

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune...

BVXV : 2.17 (+3.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BiondVax Pharmaceuticals Ltd. is a biopharmaceutical company. The company's product includes Multimeric-001 universal flu vaccine which provides multi-season and multi-strain protection against human influenza virus strains. BiondVax Pharmaceuticals Ltd. is based in Ness Ziona, Israel.

See More

Key Turning Points

3rd Resistance Point 2.21
2nd Resistance Point 2.18
1st Resistance Point 2.14
Last Price 2.17
1st Support Level 2.07
2nd Support Level 2.04
3rd Support Level 2.00

See More

52-Week High 19.65
Fibonacci 61.8% 12.92
Fibonacci 50% 10.84
Fibonacci 38.2% 8.76
Last Price 2.17
52-Week Low 2.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar